MAP2K1 and B-cell non-Hodgkin lymphoma: There was no evidence of mutations in IDH2 and PLCG2, or other B‐cell lymphoma genes, including CARD11, CCND3, CREBBP, EP300, EZH2, FOXO1, MAP2K1, MEF2B, and MYD88.